* Diebold Nixdorf Inc DBD.N DBD is expected to show a
rise in
quarterly revenue when it reports results on May 3.
* The Hudson Ohio-based company is expected to report a
5.0% increase in revenue to $871.47 million from $829.8 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. The company's guidance on March 21
2023, for the period ended March 31, was for revenue of $835.000
million.
* Refinitiv's mean analyst estimate for Diebold Nixdorf Inc
is
for earnings of 7 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Diebold
Nixdorf
Inc is $3.25, above its last closing price of $0.81.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.38 0.38 0.79 Beat 107.9
Sep. 30 2022 0.18 0.24 -0.12 Missed -149.5
Jun. 30 2022 -0.12 -0.14 0.38 Beat 371.4
Mar. 31 2022 -0.22 -0.21 -1.61 Missed -648.8
Dec. 0.56 0.57 0.06 Missed -89.4
31 2021
Sep. 30 2021 0.51 0.51 0.34 Missed -33.3
Jun. 30 2021 0.28 0.28 0.10 Missed -64.6
Mar. 31 2021 0.18 0.20 0.29 Beat 42.6
This summary was machine generated May 1 at 18:32 GMT. All
figures in US dollars unless otherwise stated